NORDEN GROUP LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1990699 PROVO, UT

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,025,723

-$227,499 QoQ

Shares Held

1,645

+1.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#640

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORDEN GROUP LLC holds $6,505,916 across 12 Biotechnology names. REGN ranks #2 (15.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,542	$1,759,417
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,645	$1,025,723
3	HALO	Halozyme Therapeutics, Inc.	9,260	$724,780
4	LGND	Ligand Pharmaceuticals Inc	1,783	$563,588
5	ALNY	Alnylam Pharmaceuticals, Inc.	1,792	$539,445
6	TGTX	Tg Therapeutics, Inc.	7,461	$409,907
7	PTGX	Protagonist Therapeutics, Inc	2,868	$351,559
8	TECH	BIO-TECHNE Corp	3,884	$274,404

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,025,723	1,645	+1.4%	Shares	Sole	2026-07-29
2026-03-31	$1,253,222	1,622	+11.2%	Shares	Sole	2026-04-15
2025-12-31	$1,126,158	1,459	+31.9%	Shares	Sole	2026-01-13
2025-09-30	$621,870	1,106	+103.7%	Shares	Sole	2025-10-15
2025-06-30	$285,075	543	-6.5%	Shares	Sole	2025-07-15
2025-03-31	$368,487	581	+16.2%	Shares	Sole	2025-05-07
2024-12-31	$356,165	500	-24.1%	Shares	Sole	2025-02-05
2024-09-30	$692,767	659	+58.8%	Shares	Sole	2024-10-17
2024-06-30	$436,177	415	+7.0%	Shares	Sole	2024-08-06
2024-03-31	$373,445	388	+48.1%	Shares	Sole	2024-04-30
2023-12-31	$230,111	262	—	Shares	Sole	2024-02-05
No filing history on record for this holder in this stock.